SMTL ID : 7s9x.1

Crystal structure of CDK2 liganded with compound WN378

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

monomer

Ligands

1 x 8KF: 2-[(9H-carbazol-3-yl)amino]-5-(trifluoromethyl)benzoic acid(Non-covalent)

8KF.1: 16 residues within 4Å: Chain A: K.33, I.52, L.55, L.58, I.63, V.64, L.66, L.78, F.80, F.117, C.118, V.123, D.145, F.146, L.148, A.149 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:I.52, A:L.55, A:L.55, A:L.58, A:L.58, A:I.63, A:L.66, A:L.78, A:F.80, A:F.80, A:F.117, A:V.123, A:F.146, A:F.146, A:L.148 Hydrogen bonds: A:L.58, A:F.146 Salt bridges: A:K.33

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sun, L. et al., Development of selective allosteric inhibitors of cyclin-dependent kinase 2 (CDK2). To Be Published

Release Date

2022-10-05

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence